Peptide therapies that stimulate the secretion of growth factors like CJC-1295, Ipamorelin, and Tesamorelin should be used cautiously in individuals with a history of cancer or uncontrolled tumor growth because these peptides may influence cell proliferation
However, the vast majority of the products current uses are clinical trial-based or investigational, and Retatrutide is not yet approved for routine human or animal use
These three effects work together to regulate appetite, blood sugar, and energy balance
The peptide influences laminin-5 (LN-5) expression in a temporally sophisticated mannerinitially inhibiting LN-5 to promote cellular proliferation and differentiation, then upregulating LN-5 expression during middle and late healing stages to improve the matrix environment and promote epidermal cell migration
However, some users swing too far in the opposite direction, eating very little in the evening and then waking hungry during the night